Colorectal cancer detection using targeted serum metabolic profiling

Journal of Proteome Research

Volumn 13, Issue 9, 2014, Pages 4120-4130

  Zhu, Jiangjiang ^a   Djukovic, Danijel ^a   Deng, Lingli ^a,b   Gu, Haiwei ^a   Himmati, Farhan ^a   Chiorean, E Gabriela ^a,c   Raftery, Daniel ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b XIAMEN UNIVERSITY   (China)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d USA   (United States)

Author keywords

colorectal cancer; diagnostic biomarkers; LC MS MS; metabolomics; polyps; serum metabolites; targeted metabolic profiling

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLISM; METABOLITE; METABOLOMICS; MONTE CARLO METHOD; PARTIAL LEAST SQUARES REGRESSION; POLYP; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERUM; TANDEM MASS SPECTROMETRY; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHEMISTRY; COLON POLYP; COLORECTAL TUMOR; METABOLOME; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COLONIC POLYPS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; MODELS, STATISTICAL; ROC CURVE; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84914170537     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500494u     Document Type: Article

References (60)

1. Weitz, J.; Koch, M.; Debus, J.; Höhler, T.; Galle, P. R.; Büchler, M. W. Colorectal cancer Lancet 2005, 365 (9454) 153-165
2. Siegel, R.; Ma, J.; Zou, Z.; Jemal, A. Cancer statistics, 2014 Ca-Cancer J. Clin. 2014, 64 (1) 9-29
3. Rex, D. K.; Johnson, D. A.; Anderson, J. C.; Schoenfeld, P. S.; Burke, C. A.; Inadomi, J. M. American college of gastroenterology guidelines for colorectal cancer screening 2008 Am. J. Gastroenterol. 2009, 104 (3) 739-750
4. Bond, J. H. Colon polyps and cancer Endoscopy 2003, 35 (01) 27-35
5. Levin, B.; Lieberman, D. A.; McFarland, B.; Smith, R. A.; Brooks, D.; Andrews, K. S.; Dash, C.; Giardiello, F. M.; Glick, S.; Levin, T. R.; Pickhardt, P.; Rex, D. K.; Thorson, A.; Winawer, S. J. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Ca-Cancer J. Clin. 2008, 58 (3) 130-160
6. Taylor, D. P.; Cannon-Albright, L. A.; Sweeney, C.; Williams, M. S.; Haug, P. J.; Mitchell, J. A.; Burt, R. W. Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk Genet. Med. 2011, 13 (8) 737-743
7. Cancer Facts & Figures 2013; American Cancer Society: Atlanta, GA, 2013.
8. Ahlquist, D. A.; Zou, H.; Domanico, M.; Mahoney, D. W.; Yab, T. C.; Taylor, W. R.; Butz, M. L.; Thibodeau, S. N.; Rabeneck, L.; Paszat, L. F.; Kinzler, K. W.; Vogelstein, B.; Bjerregaard, N. C.; Laurberg, S.; Sørensen, H. T.; Berger, B. M.; Lidgard, G. P. Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large Adenomas Gastroenterology 2012, 142 (2) 248-256
9. Link, A.; Balaguer, F.; Shen, Y.; Nagasaka, T.; Lozano, J. J.; Boland, C. R.; Goel, A. Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening Cancer Epidemiol., Biomarkers Prev. 2010, 19 (7) 1766-1774
10. Ahmed, F. E.; Ahmed, N. C.; Vos, P. W.; Bonnerup, C.; Atkins, J. N.; Casey, M.; Nuovo, G. J.; Naziri, W.; Wiley, J. E.; Mota, H.; Allison, R. R. Diagnostic MicroRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle Cancer Genomics Proteomics 2013, 10 (3) 93-113
11. Imperiale, T. F.; Ransohoff, D. F.; Itzkowitz, S. H.; Levin, T. R.; Lavin, P.; Lidgard, G. P.; Ahlquist, D. A.; Berger, B. M. Multitarget Stool DNA Testing for Colorectal-Cancer Screening N. Engl. J. Med. 2014, 370, 1287-1297
12. Jain, M.; Nilsson, R.; Sharma, S.; Madhusudhan, N.; Kitami, T.; Souza, A. L.; Kafri, R.; Kirschner, M. W.; Clish, C. B.; Mootha, V. K. Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation Science 2012, 336 (6084) 1040-1044
13. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009, 457 (7231) 910-914
14. Wise, D. R.; Thompson, C. B. Glutamine addiction: a new therapeutic target in cancer Trends Biochem. Sci. 2010, 35 (8) 427-433
15. Munoz-Pinedo, C.; El Mjiyad, N.; Ricci, J. E. Cancer metabolism: current perspectives and future directions Cell Death Dis. 2012, 3, e248
16. Gross, S.; Cairns, R. A.; Minden, M. D.; Driggers, E. M.; Bittinger, M. A.; Jang, H. G.; Sasaki, M.; Jin, S.; Schenkein, D. P.; Su, S. M.; Dang, L.; Fantin, V. R.; Mak, T. W. Cancer-Associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations J. Exp. Med. 2010, 207 (2) 339-344
17. Patti, G. J.; Yanes, O.; Siuzdak, G. Innovation: Metabolomics: the apogee of the omics trilogy Nat. Rev. Mol. Cell Biol. 2012, 13 (4) 263-269
18. Gu, H.; Gowda, G. A. N.; Raftery, D. Metabolic profiling: are we en route to better diagnostic tests for cancer? Future Oncol. 2012, 8 (10) 1207-1210
19. Gowda, G. A. N.; Zhang, S.; Gu, H.; Asiago, V.; Shanaiah, N.; Raftery, D. Metabolomics-based methods for early disease diagnostics Expert Rev. Mol. Diagn. 2008, 8 (5) 617-633
20. Scalbert, A.; Brennan, L.; Fiehn, O.; Hankemeier, T.; Kristal, B.; Ommen, B.; Pujos-Guillot, E.; Verheij, E.; Wishart, D.; Wopereis, S. Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research Metabolomics 2009, 5 (4) 435-458
21. Nicholson, J. K.; Holmes, E.; Kinross, J. M.; Darzi, A. W.; Takats, Z.; Lindon, J. C. Metabolic phenotyping in clinical and surgical environments Nature 2012, 491 (7424) 384-392
22. Fan, T.-M.; Lane, A. NMR-based stable isotope resolved metabolomics in systems biochemistry J. Biomol. NMR 2011, 49 (3-4) 267-280
23. Reaves, M. L.; Rabinowitz, J. D. Metabolomics in systems microbiology Curr. Opin. Biotechnol. 2011, 22 (1) 17-25
24. Bain, J. R.; Stevens, R. D.; Wenner, B. R.; Ilkayeva, O.; Muoio, D. M.; Newgard, C. B. Metabolomics Applied to Diabetes Research: Moving From Information to Knowledge Diabetes 2009, 58 (11) 2429-2443
25. Yanes, O.; Tautenhahn, R.; Patti, G. J.; Siuzdak, G. Expanding Coverage of the Metabolome for Global Metabolite Profiling Anal. Chem. 2011, 83 (6) 2152-2161
26. Spratlin, J. L.; Serkova, N. J.; Eckhardt, S. G. Clinical Applications of Metabolomics in Oncology: A Review Clin. Cancer Res. 2009, 15 (2) 431-440
27. Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Zheng, X.; Xu, Y.; Ni, Y.; Zhao, A.; Xu, L. X.; Cai, S.; Jia, W. Serum Metabolite Profiling of Human Colorectal Cancer Using GC-TOFMS and UPLC-QTOFMS J. Proteome Res. 2009, 8 (10) 4844-4850
28. Nishiumi, S.; Kobayashi, T.; Ikeda, A.; Yoshie, T.; Kibi, M.; Izumi, Y.; Okuno, T.; Hayashi, N.; Kawano, S.; Takenawa, T.; Azuma, T.; Yoshida, M.; Novel Serum, A. Metabolomics-Based Diagnostic Approach for Colorectal Cancer PLoS One 2012, 7 (7) e40459
29. Tan, B.; Qiu, Y.; Zou, X.; Chen, T.; Xie, G.; Cheng, Y.; Dong, T.; Zhao, L.; Feng, B.; Hu, X.; Xu, L. X.; Zhao, A.; Zhang, M.; Cai, G.; Cai, S.; Zhou, Z.; Zheng, M.; Zhang, Y.; Jia, W. Metabonomics Identifies Serum Metabolite Markers of Colorectal Cancer J. Proteome Res. 2013, 12 (6) 3000-3009
30. Denkert, C.; Budczies, J.; Weichert, W.; Wohlgemuth, G.; Scholz, M.; Kind, T.; Niesporek, S.; Noske, A.; Buckendahl, A.; Dietel, M.; Fiehn, O. Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover Mol. Cancer 2008, 7 (1) 72
31. Chan, E. C. Y.; Koh, P. K.; Mal, M.; Cheah, P. Y.; Eu, K. W.; Backshall, A.; Cavill, R.; Nicholson, J. K.; Keun, H. C. Metabolic Profiling of Human Colorectal Cancer Using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Gas Chromatography Mass Spectrometry (GC/MS) J. Proteome Res. 2008, 8 (1) 352-361
32. Ma, Y.-L.; Qin, H.-L.; Liu, W.-J.; Peng, J.-Y.; Huang, L.; Zhao, X.-P.; Cheng, Y.-Y. Ultra-High Performance Liquid Chromatography-Mass Spectrometry for the Metabolomic Analysis of Urine in Colorectal Cancer Dig. Dis. Sci. 2009, 54 (12) 2655-2662
33. Li, F.; Qin, X.; Chen, H.; Qiu, L.; Guo, Y.; Liu, H.; Chen, G.; Song, G.; Wang, X.; Li, F.; Guo, S.; Wang, B.; Li, Z. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry Rapid Commun. Mass Spectrom. 2013, 27 (1) 24-34
34. Ritchie, S.; Ahiahonu, P.; Jayasinghe, D.; Heath, D.; Liu, J.; Lu, Y.; Jin, W.; Kavianpour, A.; Yamazaki, Y.; Khan, A.; Hossain, M.; Su-Myat, K.; Wood, P.; Krenitsky, K.; Takemasa, I.; Miyake, M.; Sekimoto, M.; Monden, M.; Matsubara, H.; Nomura, F.; Goodenowe, D. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection BMC Med. 2010, 8 (1) 13
35. Ritchie, S. A.; Tonita, J.; Alvi, R.; Lehotay, D.; Elshoni, H.; Myat, S.; McHattie, J.; Goodenowe, D. B. Low-serum GTA-446 anti-inflammatory fatty acid levels as a new risk factor for colon cancer Int. J. Cancer 2013, 132 (2) 355-362
36. Xu, Q.-S.; Liang, Y.-Z. Monte Carlo cross validation Chemom. Intell. Lab. Syst. 2001, 56 (1) 1-11
37. Chong, I.-G.; Jun, C.-H. Performance of some variable selection methods when multicollinearity is present Chemom. Intell. Lab. Syst. 2005, 78 (1-2) 103-112
38. Rocha, C. u. M.; Carrola, J.; Barros, A. n. S.; Gil, A. M.; Goodfellow, B. J.; Carreira, I. M.; Bernardo, J. o.; Gomes, A.; Sousa, V.; Carvalho, L.; Duarte, I. F. Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma J. Proteome Res. 2011, 10 (9) 4314-4324
39. Wei, S.; Suryani, Y.; Gowda, G. A. N.; Skill, N.; Maluccio, M.; Raftery, D. Differentiating Hepatocellular Carcinoma from Hepatitis C Using Metabolite Profiling Metabolites 2012, 2 (4) 701-716
40. Rhee, E. P.; Ho, J. E.; Chen, M.-H.; Shen, D.; Cheng, S.; Larson, M. G.; Ghorbani, A.; Shi, X.; Helenius, I. T.; O'Donnell, C. J.; Souza, A. L.; Deik, A.; Pierce, K. A.; Bullock, K.; Walford, G. A.; Vasan, R. S.; Florez, J. C.; Clish, C.; Yeh, J. R. J.; Wang, T. J.; Gerszten, R. E. A Genome-wide Association Study of the Human Metabolome in a Community-Based Cohort Cell Metab. 2013, 18 (1) 130-143
41. Benjamin, D. I.; Cravatt, B. F.; Nomura, D. K. Global Profiling Strategies for Mapping Dysregulated Metabolic Pathways in Cancer Cell Metab. 2012, 16 (5) 565-577
42. Gu, H.; Pan, Z.; Xi, B.; Asiago, V.; Musselman, B.; Raftery, D. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: Application to the detection of breast cancer Anal. Chim. Acta 2011, 686 (1-2) 57-63
43. Bajad, S. U.; Lu, W.; Kimball, E. H.; Yuan, J.; Peterson, C.; Rabinowitz, J. D. Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry J. Chromatogr. A 2006, 1125 (1) 76-88
44. Yuan, M.; Breitkopf, S. B.; Yang, X.; Asara, J. M. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue Nat. Protoc. 2012, 7 (5) 872-881
45. Wei, R.; Li, G.; Seymour, A. B. High-Throughput and Multiplexed LC/MS/MRM Method for Targeted Metabolomics Anal. Chem. 2010, 82 (13) 5527-5533
46. Leichtle, A.; Nuoffer, J.-M.; Ceglarek, U.; Kase, J.; Conrad, T.; Witzigmann, H.; Thiery, J.; Fiedler, G. Serum amino acid profiles and their alterations in colorectal cancer Metabolomics 2012, 8 (4) 643-653
47. Ong, E. S.; Zou, L.; Li, S.; Cheah, P. Y.; Eu, K. W.; Ong, c. N. Metabolic profiling in colorectal cancer reveals signature metabolic shifts during tumorigenesis Mol. Cell. Proteomics 2010, 10.1074/mcp.M900551-MCP200
48. Eisner, R.; Greiner, R.; Tso, V.; Wang, H.; Fedorak, R. N. A Machine-Learned Predictor of Colonic Polyps Based on Urinary Metabolomics BioMed. Res. Int. 2013, 2013, 11
49. Schoen, R. E.; Tangen, C. M.; Kuller, L. H.; Burke, G. L.; Cushman, M.; Tracy, R. P.; Dobs, A.; Savage, P. J. Increased blood glucose and insulin, body Size, and incident colorectal cancer J. Natl. Cancer Inst. 1999, 91 (13) 1147-1154
50. Ehrmann-Jósko, A.; Siemińska, J.; Górnicka, B.; Ziarkiewicz-Wróblewska, B.; Ziókowski, B.; Muszyński, J. Impaired glucose metabolism in colorectal cancer Scand. J. Gastroenterol. 2006, 41 (9) 1079-1086
51. Warburg, O. On the Origin of Cancer Cells Science 1956, 123 (3191) 309-314
52. Vander Heiden, M. G.; Cantley, L. C.; Thompson, C. B. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation Science 2009, 324 (5930) 1029-1033
53. Hirayama, A.; Kami, K.; Sugimoto, M.; Sugawara, M.; Toki, N.; Onozuka, H.; Kinoshita, T.; Saito, N.; Ochiai, A.; Tomita, M.; Esumi, H.; Soga, T. Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry Cancer Res. 2009, 69 (11) 4918-4925
54. Garcia-Caballero, M.; Neugebauer, E.; Campos, R.; Nunez de Castro, I.; Vara-Thorbeck, C. Increased histidine decarboxylase (HDC) activity in human colorectal cancer: Results of a study on ten patients Agents Actions 1988, 23 (3-4) 357-360
55. Argilés, J.; Azcón-Bieto, J. The metabolic environment of cancer Mol. Cell. Biochem. 1988, 81 (1) 3-17
56. Huang, Q.; Tan, Y.; Yin, P.; Ye, G.; Gao, P.; Lu, X.; Wang, H.; Xu, G. Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics Cancer Res. 2013, 73 (16) 4992-5002
57. Weber, G. Enzymes of purine metabolism in cancer Clin. Biochem. 1983, 16 (1) 57-63
58. Israel, M.; Schwartz, L. The metabolic advantage of tumor cells Mol. Cancer 2011, 10 (1) 70
59. Tocchi, A.; Basso, L.; Costa, G.; Lepre, L.; Liotta, G.; Mazzoni, G.; Sita, A.; Tagliacozzo, S. Is there a causal connection between bile acids and colorectal cancer? Surg. Today 1996, 26 (2) 101-104
60. Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Liu, Y.; Xu, Y.; Ni, Y.; Zhao, A.; Cai, S.; Xu, L. X.; Jia, W. Urinary Metabonomic Study on Colorectal Cancer J. Proteome Res. 2010, 9 (3) 1627-1634